Tepotinib for treating advanced non-small-cell lung cancer with MET gene alterations

  • Technology appraisal guidance
  • TA789
  • Published: 
Download guidance (PDF)

Update information

June 2025: We changed the tablet composition in section 2.3 to align with the summary of product characteristics.

ISBN: 978-1-4731-4589-4